Publication | Closed Access

Anticancer activity of a novel naringin‒dextrin nanoformula: Preparation, characterization, and in vitro induction of apoptosis in human hepatocellular carcinoma cells by inducing ROS generation, DNA fragmentation, and cell cycle arrest

NanomedicineDrug TargetingNanotherapeuticsMedicineCell DeathCell Cycle ArrestAnticancer ActivityTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyCancer ResearchNovel Naringin‒dextrin Nanoformula